Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

• Автори: Yufei Wang (Автор), Wanbo Tai (Автор), Jie Yang (Автор), Guangyu Zhao (Автор), Shihui Sun (Автор), Chien-Te K. Tseng (Автор), Shibo Jiang (Автор), Yusen Zhou (Автор), Lanying Du (Автор), Jimin Gao (Автор)
• Формат: Книга
• Опубліковано: Taylor & Francis Group, 2017-07-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS vaccines highlight the need to develop safe and effective vaccines against MERS. We have previously demonstrated that a receptor-binding domain (RBD)...